Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

Why Choose EvoLV: A Local Perspective on Pharmaceutical Consulting

May 04, 2025

Understanding the Value of Pharmaceutical Consulting

In the rapidly evolving world of pharmaceuticals, staying ahead of the curve is essential. Whether you're a startup or an established company, navigating the complexities of pharmaceutical regulations, market entry strategies, and compliance is crucial. This is where pharmaceutical consulting firms like EvoLV play a pivotal role. With their expertise, they provide invaluable insights and strategies to help businesses thrive in this competitive industry.

pharmaceutical consulting

Why Local Expertise Matters

Choosing a local consulting firm like EvoLV offers numerous advantages. Understanding local regulations, market dynamics, and customer preferences provides a distinct edge. EvoLV, with its deep-rooted local presence, ensures that your business not only complies with regulatory standards but also aligns with market expectations.

Moreover, a local consultant is more accessible and offers personalized service, which can be a game-changer in addressing specific challenges and opportunities unique to your region. EvoLV's team is always just a call away, ready to provide tailored solutions that cater to your needs.

Comprehensive Services Offered by EvoLV

EvoLV boasts a wide range of services designed to meet the diverse needs of their clients. From regulatory affairs and compliance management to market entry strategies and clinical development consulting, they cover all aspects of pharmaceutical consulting. Their team of seasoned professionals ensures that every project is handled with precision and expertise.

pharmaceutical team

One of the standout features of EvoLV is their ability to customize their services. They understand that every client has unique needs and challenges, and they pride themselves on offering bespoke solutions that align with specific business goals.

Client-Centric Approach

EvoLV’s commitment to a client-centric approach sets them apart from other consulting firms. They prioritize building lasting relationships based on trust and transparency. Regular updates, open communication, and collaborative problem-solving are integral to their service delivery model.

This approach not only ensures successful project outcomes but also fosters a strong partnership between EvoLV and their clients. Their dedication to client satisfaction has earned them a reputation for excellence in the pharmaceutical consulting industry.

client meeting

Proven Track Record of Success

With a proven track record of helping numerous pharmaceutical companies achieve their objectives, EvoLV has established itself as a leader in the field. Their portfolio showcases successful collaborations with a variety of clients, from innovative biotech startups to large multinational corporations.

Testimonials from satisfied clients highlight EvoLV’s ability to deliver results-driven solutions that exceed expectations. Their expertise and strategic insights have played a crucial role in guiding companies through complex regulatory landscapes and competitive markets.

Investing in Innovation and Technology

Innovation is at the core of EvoLV’s philosophy. They continuously invest in cutting-edge technology and industry research to offer their clients the latest insights and tools. This commitment to innovation ensures that they remain at the forefront of industry trends and advancements.

By leveraging technology, EvoLV enhances their consulting services, providing clients with data-driven strategies that drive growth and success. Their forward-thinking approach empowers businesses to adapt and thrive in an ever-changing pharmaceutical landscape.